Skip to main content

Table 5 TEAEs Leading to Discontinuation by System Organ Class and Preferred Term (All Occurrences: Safety Population, N = 129)

From: A 13-hour laboratory school study of lisdexamfetamine dimesylate in school-aged children with attention-deficit/hyperactivity disorder

System Organ Class

Preferred Term

n (%)

Gastrointestinal

 

4 (3.1)

 

Abdominal pain

2 (1.6)

 

Diarrhea

1 (0.8)

 

Nausea

2 (1.6)

 

Vomiting

2 (1.6)

General

 

4 (3.1)

 

Fatigue

2 (1.6)

 

Irritability

2 (1.6)

Investigations

 

1 (0.8)

 

Weight decrease

1 (0.8)

Metabolic/nutritional

 

3 (2.3)

 

Anorexia

2 (1.6)

 

Decreased appetite

1 (0.8)

Nervous system

 

2 (1.6)

 

Amnesia

1 (0.8)

 

Psychomotor hyperactivity

2 (1.6)

 

Tardive dyskinesia

(lip-smacking)

1 (0.8)

Psychiatric

 

5 (3.9)

 

Insomnia/sleep disorder

4 (3.1)

 

Suicidal ideation

1 (0.8)

 

Tearfulness

1 (0.8)

  1. TEAEs: treatment-emergent adverse events